Physician profile
Omer Acar
NPI 1376037010
$4,741.26
in general payments reported to CMS, 2019-2025
9 companies · $251 in 2025
The $251 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.25 · 2020: $110 · 2021: $19.91 · 2022: $1,224 · 2023: $1,277 · 2024: $1,811 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,971 · Food and Beverage: $1,368.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,970.92 |
| Food and Beverage | $1,367.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,354.97 | 2024 | Aquabeam System |
| Coloplast Corp | $1,272.64 | 2022-2025 | Virtue, Titan |
| Medtronic, INC. | $989.68 | 2023-2024 | Interstim, Stealthstation S8 Platform |
| Olympus America INC. | $603.75 | 2022-2025 | Itind System |
| Boston Scientific Corporation | $234.99 | 2020-2025 | Lithovue, Ams 800 Artificial Urinary Sphincter, Lumenis Pulse 120h |
| Laborie Medical Technologies Corp. | $147.09 | 2023 | |
| Axonics, INC. | $69.98 | 2023 | Axonics, Bulkamid |
| Astellas Pharma US INC | $48.25 | 2019 | |
| Blue Earth Diagnostics | $19.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Omer Acar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.